Page 124 - 南京医科大学自然版
P. 124
第45卷第6期
·862 · 南 京 医 科 大 学 学 报 2025年6月
after catheter ablation［J］. BMC Cardiovasc Disord，2020， terious effects of obesity and inflammation on the myocar⁃
20（1）：427 dium［J］. J Am Coll Cardiol，2018，71（20）：2360-2372
［18］TØNNESEN J，PALLISGAARD J，RUWALD M H，et al. ［22］QIU Y，GUO H，WANG S，et al. Deep learning⁃based mul⁃
Short⁃ and long⁃term risk of atrial fibrillation recurrence timodal fusion of the surface ECG and clinical features in
after first time ablation according to body mass index：a prediction of atrial fibrillation recurrence following cathe⁃
nationwide danish cohort study［J］. Europace，2023，25 ter ablation［J］. BMC Med Inform Decis Mak，2024，24
（2）：425-432 （1）：225
［19］STRITZKE J，MARKUS M R，DUDERSTADT S，et al. ［23］JOGLAR J A，CHUNG M K，ARMBRUSTER A L，et al.
The aging process of the heart：obesity is the main risk 2023 ACC/AHA/ACCP/HRS guideline for the diagnosis
factor for left atrial enlargement during aging the MONI⁃ and management of atrial fibrillation：a report of the Amer⁃
CA/KORA（monitoring of trends and determinations in ican College of Cardiology/American Heart Association
cardiovascular disease/cooperative research in the region Joint Committee on clinical practice guidelines［J］. Circu⁃
of augsburg）study［J］. J Am Coll Cardiol，2009，54（21）： lation，2024，149（1）：e1-e156
1982-1989 ［24］CROWLEY R，CHIENG D，SEGAN L，et al. Persistent
［20］MAHAJAN R，NELSON A，PATHAK R K，et al. Electro⁃ atrial fibrillation phenotypes and ablation outcomes：per⁃
anatomical remodeling of the atria in obesity：impact of sistent from outset vs progression from paroxysmal AF［J］.
adjacent epicardial fat［J］. JACC Clin Electrophysiol， JACC Clin Electrophysiol，2024，11（1）：10-18
2018，4（12）：1529-1540 ［收稿日期］ 2025-01-09
［21］PACKER M. Epicardial adipose tissue may mediate dele⁃ （本文编辑：唐 震）
（上接第836页） markers in diabetic kidney disease［J］. Chinese Journal of
［24］KHANIJOU V，ZAFARI N，COUGHLAN M T，et al. Re⁃ Nephrology，2022，38（8）：771-784
view of potential biomarkers of inflammation and kidney ［27］黄婧荷，宋 焱，郭立新. 糖尿病肾脏病的磁共振成像
injury in diabetic kidney disease［J］. Diabetes Metab Res 评估方法及进展［J］. 国际内分泌代谢杂志，2023，43
Rev，2022，38（6）：e3556 （4）：309-312
［25］JIANG X R，LIU X Y，QU X T，et al. Integration of metab⁃ HUANG J H，SONG Y，GUO L X，et al. Magnetic reso⁃
olomics and peptidomics reveals distinct molecular land⁃ nance imaging in diabetic kidney disease：assessment and
scape of human diabetic kidney disease［J］. Theranostics， update［J］. International Journal of Endocrinology and
2023，13（10）：3188-3203 Metabolism，2023，43（7）：561-566
［26］中华医学会肾脏病学分会专家组. 糖尿病肾脏疾病诊 ［28］SANDHOLM N，DAHLSTRÖM E H，GROOP P H. Genetic
断、预后评估和生物标志物应用专家共识［J］. 中华肾 and epigenetic background of diabetic kidney disease［J］.
脏病杂志，2022，38（8）：771-784 Front Endocrinol（Lausanne），2023，14：1163001
Chinese Society of Nephrology. Expert consensus on the ［收稿日期］ 2024-12-05
diagnosis，prognosis assessment，and application of bio⁃ （本文编辑：陈汐敏）
